David Schiff MD
Neurooncology
Harrison Distinguished Teaching Professor of Neurology, University of Virginia School of Medicine
Join to View Full Profile
1240 Lee StFl 3Charlottesville, VA 22908
Phone+1 434-924-9333
Fax+1 434-982-4467
Dr. Schiff is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Schiff is a Charlottesville, VA-based neurologist specializing in neurooncology, particularly experienced in neuro-oncology, meningiomas, and pediatric neuro-oncology. He completed his medical education at Harvard Medical School, followed by an internship in Internal Medicine at Brigham and Women's Hospital. Dr. Schiff has contributed to several notable publications covering topics like glioblastoma growth and management of gliomas. He is involved in various clinical trials focusing on innovative treatments for glioblastoma and recurrent meningioma. He has received CMS Meaningful Use Stage 1 Certifications from EpicCare for both ambulatory and inpatient care systems.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Neurology, 2019 - 2023
Mass General Brigham/Brigham and Women's HospitalInternship, Internal Medicine, 1988 - 1989
Harvard Medical SchoolClass of 1988
Certifications & Licensure
AZ State Medical License 1996 - Present
VA State Medical License 2001 - 2026
PA State Medical License 1996 - 2002
MN State Medical License 1993 - 1997
NY State Medical License 1992 - 1994
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
Clinical Trials
- Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor Start of enrollment: 2003 Jun 01
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Mar 01
- A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Aug 01
Publications & Presentations
PubMed
- Practical Management of Headaches in Patients With Primary and Secondary Brain Tumors.Megan E H Still, Joy Burke, Jennifer Robblee, Surabhi Ranjan, Nestor Galvez-Jimenez
Journal of Pain and Symptom Management. 2026-08-01 - 4 citationsImmunodeficiency-associated primary CNS lymphomas: an International Primary CNS Lymphoma Collaborative Group study.Leon D Kaulen, Lakshmi Nayak, Philipp Karschnia, Imke Kraai, Daniela Galluzzo
Blood. 2026-07-02 - Discovery and therapeutic delivery of microRNAs targeting deregulated glioblastoma pathways inhibits tumor growth in mice.Shekhar Saha, Ying Zhang, Myron K Gibert Jr, Collin Dube, Farina Hanif
The Journal of Clinical Investigation. 2026-06-30
Journal Articles
- Phase I Study of Pomalidomide and Dexamethasone for relapsed/refractory Primary CNS or Vitreo-Retinal LymphomaLisa M DeAngelis, Han W Tun, David Schiff, Kurt A Jaeckle, Christian Grommes, Patrick B Johnston, Craig B Reeder, Thomas E Witzig, Blood
Other
- Discovery and Therapeutic Exploitation of Mechanisms of Resistance to MET Inhibitors in GlioblastomaDavid Schiff, MD, Clinical Cancer Research
https://www.doximity.com/articles/e5ba8350-d6fc-4d24-833f-8632cfbcc6e1
UpToDate, Wolters Kluwer Health - 2012-10-03 - Discovery and Therapeutic Exploitation of Mechanisms of Resistance to MET Inhibitors in GlioblastomaDavid Schiff, MD, Clinical Cancer Research
https://www.doximity.com/articles/e5ba8350-d6fc-4d24-833f-8632cfbcc6e1
UpToDate, Wolters Kluwer Health - 2012-04-09 - Discovery and Therapeutic Exploitation of Mechanisms of Resistance to MET Inhibitors in GlioblastomaDavid Schiff, MD, Clinical Cancer Research
https://www.doximity.com/articles/e5ba8350-d6fc-4d24-833f-8632cfbcc6e1
UpToDate, Wolters Kluwer Health - 2012-08-28
Press Mentions
Paving New ROADS in the Treatment of Brain Metastases with Implanted Tile-Based Radiation TherapyJune 29th, 2026- UVA Leverages AI Technology to Enhance Brain Cancer TreatmentAugust 7th, 2025
- New AI Tool Could Expedite Treatment Decisions for Glioblastoma PatientsAugust 7th, 2025
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
